SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016659
Filing Date
2022-11-07
Accepted
2022-11-07 17:21:19
Documents
90
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20220930x10q.htm   iXBRL 10-Q 2288902
2 EX-10.1 ymab-20220930xex10d1.htm EX-10.1 98536
3 EX-10.2 ymab-20220930xex10d2.htm EX-10.2 99271
4 EX-10.3 ymab-20220930xex10d3.htm EX-10.3 159234
5 EX-31.1 ymab-20220930xex31d1.htm EX-31.1 15959
6 EX-31.2 ymab-20220930xex31d2.htm EX-31.2 15551
7 EX-32.1 ymab-20220930xex32d1.htm EX-32.1 7971
8 EX-32.2 ymab-20220930xex32d2.htm EX-32.2 7724
  Complete submission text file 0001558370-22-016659.txt   8813580

Data Files

Seq Description Document Type Size
9 EX-101.SCH ymab-20220930.xsd EX-101.SCH 67514
10 EX-101.CAL ymab-20220930_cal.xml EX-101.CAL 50070
11 EX-101.DEF ymab-20220930_def.xml EX-101.DEF 252425
12 EX-101.LAB ymab-20220930_lab.xml EX-101.LAB 529650
13 EX-101.PRE ymab-20220930_pre.xml EX-101.PRE 423776
84 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20220930x10q_htm.xml XML 1318957
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 221366519
SIC: 2834 Pharmaceutical Preparations